Lancashire and South Cumbria
Formulary
Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-04-01 Alpha-blockers
| Tamsulosin |
|
Formulary
|
M/R capsules 400 microgram Urinary retention. |
|
| Doxazosin |
|
Formulary
|
Tablets 1mg, 2mg, 4mg Urinary retention. |
 LSCMMG: Doxazosin Modified Release |
|
|
Links
- FSRH Clinical Guideline: Contraceptive Choices for Young People
- FSRH: Standards & Guidance
- FSRH: UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)
- LSCMMG: Doxazosin Modified Release
LSCMMG: Primary Care Management of Erectile Dysfunction- LSCMMG: Primary Care Management of Overactive Bladder in Female Adults
- MHRA: Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
- NICE CG30: Long-acting reversible contraception
- NICE CG97: Lower urinary tract symptoms in men: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG194: Postnatal care
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE NG88: Heavy menstrual bleeding: assessment and management
UKMI Q&A: How should conversion between doxazosin formulations be carried out?